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The steroidogenic acute regulatory protein (StAR) plays a critical role in trophic hormone-stimulated steroid biosynthesis by facilitating the transfer of cholesterol, the substrate for all steroid hormones, to the inner mitochondrial membrane where it is converted to pregnenolone by the P450 side chain cleavage enzyme (P450scc) (1) (2) (3) (4) .
However, the manner in which trophic hormones regulate StAR gene expression is not entirely clear. It is generally accepted that trophic hormones, such as luteinizing hormone (LH) or adrenal corticotrophic hormone (ACTH) stimulate cyclic AMP (cAMP) formation followed by activation of protein kinase A (PKA) which in turn phosphorylates known transcription factors and possibly additional unknown factors which regulate StAR gene transcription (5) . However, it is also known that trophic hormones induce arachidonic acid (AA) release in steroidogenic cells and that this release is a requisite for steroid biosynthesis. Following LH stimulation, AA was released within one minute in rat testicular Leydig cells (6) . Also, AA release occurred in a dose and time-dependent manner in human chorionic gonadotrophin (hCG)-stimulated Leydig cells, with the amount of AA released being dependent on hormone-receptor interaction and the concentration of LH/hCG binding sites on the cell surface (7) . Recently, an ACTHinduced 43 kDa protein, named arachidonic acid-related thioesterase involved in steroidogenesis (ARTISt), was identified and cloned from rat adrenal cells. ARTISt demonstrated the highest substrate specifity when assayed with arachidonyl-CoA and was reported to play a role in steroid synthesis by regulating AA release from arachidonylCoA (8) .
The role of AA in trophic hormone-stimulated steroid production in various steroidogenic cells has been well documented over the last twenty years (9-13), however, the mechanism responsible for the role of AA remains unknown. Since previous studies suggested that AA and its metabolites act at the rate-limiting step of steroid biosynthesis, cholesterol transfer to the inner mitochondrial membrane (14, 15) , we reasoned that the StAR protein might be involved in the role of AA in the regulation of steroidgenesis.
This hypothesis was proven correct by our recent studies, which indicated that AA release is essential for StAR protein expression (16) Cell culture--The MA-10 mouse Leydig tumor cells were a generous gift from Dr.
Mario Ascoli (Dept. of Pharmacology, University of Iowa, College of Medicine, Iowa City) and were grown in 100 mm tissue culture dishes in Waymouth's MB/752 medium containing 15% horse serum as previously described (17) . The cells were cultured in incubators at 37 o C and 5% CO 2 . Before each experiment, the medium was replaced with serum-free Waymouth's medium.
Steroid production--MA-10 cells were cultured for 30 min in serum-free Waymouth's medium containing AA, and/or its metabolic inhibitors (as described in the Figure   Legends ) and then stimulated with 0.5 mM dbcAMP for 6 h. Western blot analysis as described previously (21) . Western analysis experiments were performed at least three times and the results of one representative experiment shown.
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Statistical analyses--Each experiment was repeated at least three times. Statistical analysis of the data was performed with ANOVA using Stat View SE system (Abacus Concepts, Berkeley, CA).
RESULTS:

Effects of arachidonic acid on StAR protein expression and steroid production--To
determine the effects of AA release on StAR protein expression and steroid hormone production, dbcAMP-stimulated MA-10 mouse Leydig cells were treated with the PLA2
inhibitor, dexamethasone which inhibits AA release from phospholipids. As shown in hydroxycholesterol was added to each treatment. There was no significant difference in progesterone production among the treatments when 22(R) hydroxycholesterol was added to the culture medium. In order to confirm that the inhibitory effects of dexamethasone were due to the inhibition of AA release, 150 µM AA was added to the dbcAMPstimulated MA-10 cells treated with 1.0 µM dexamethasone. While dbcAMP-stimulated StAR protein expression and steroid production were significantly inhibited by dexamethasone (P < 0.01), addition of AA into the culture medium reversed the inhibitory effects (Fig. 2) . AA in the absence of dbcAMP did not increase either StAR protein or progesterone production significantly. (Fig. 3B) . The reduction of StAR mRNA was reversed by the addition of AA to the cells (Fig. 4A) . While 1.0 µM dexamethasone significantly reduced dbcAMP-stimulated StAR mRNA (P < 0.01), 150
Effect of arachidonic acid on StAR gene transcription--To
µM AA significantly reversed this inhibition (P < 0.01). A similar reversal was observed in dexamethasone-inhibited StAR promoter activity (Fig. 4B) . Importantly, AA alone did not increase StAR mRNA, and slightly, but not significantly, increased StAR promoter activity.
Roles of arachidonic acid metabolites in StAR protein expression and steroid
production--In order to examine which metabolic pathway of AA might be involved in StAR protein expression, dbcAMP-stimulated MA-10 cells were treated with the lipoxygenase inhibitors NDGA or AA861, the epoxygenase inhibitor miconazole, and the cyclooxygenase inhibitor indomethacin, respectively. StAR protein levels and progesterone production were determined. As shown in Fig. 5 , both NDGA and AA861
inhibited both StAR protein expression and progesterone production (P < 0.01).
Miconazole slightly inhibited StAR protein expression, but significantly inhibited progesterone production (P < 0.01). Indomethacin caused an increase in StAR protein and also resulted in a significant increase in progesterone production (P < 0.01). Based on these results, we continued the studies on the lipoxygenase pathway. AA861-treated MA-10 cells were incubated in a medium containing 1.5 µM of 5-HPETE, a metabolite of the 5-lipoxygenase pathway. The results are shown in Fig. 6 . Addition of 5-HPETE to the cell cultures partially reversed AA861-inhibited StAR protein and also partially reversed the inhibition in progesterone production (P < 0.01).
PKA activity and arachidonic acid in StAR protein expression--dbcAMP-stimulated
MA-10 cells were treated with the PKA inhibitor H89, the PLA2 inhibitor 
DISCUSSION
Arachidonic acid (AA) is well known as a component of phospholipids in cell membranes and cytosolic free AA is mainly generated through the activation of PLA2 which catalyzes its release from phospholipids (22, 23) . Metabolism of the released AA through one of the three enzyme systems, namely, the lipoxygenase, the cyclooxygenase or the cytochrome P450-dependent epoxygenase pathways, produces various metabolites (24, 25) . In recent years, the regulatory effects of AA and its metabolites on steroid hormone biosynthesis has been demonstrated (26, 27, 28) , but the mechanisms for the effects of AA are not clear.
The results of the present study indicate that AA release is essential for steroid production and StAR protein expression. Inhibition of AA release by the PLA2 inhibitor, dexamethasone, reduced dbcAMP-stimulated StAR protein to a remarkably low level.
As StAR protein decreased, progesterone production was concommitantly decreased (P < 0.01). The inhibitory effect of dexamethasone was clearly not due to an inhibitory effect on the activities of the P450scc and/or 3β-HSD enzymes. There was no significant difference in steroid production in any of the treatments when 22(R)hydroxycholesterol was added to the MA-10 cell cultures, indicating that these enzymes were unaffected by dbcAMP-stimulated steroid production and StAR protein expression using quinacrine as a PLA2 inhibitor (16) . Dexamethasone, which is used in the present study, inhibits PLA2 activity through a mechanism different from that of the effects of quinacrine (29, 30) .
However, the results from these two inhibitors were essentially identical and, thus corroborated our earlier observations. Since StAR protein was demonstrated to play a critical role in cholesterol transfer to the mitochondrial inner membrane (1-4), these results are in agreement with the earlier experiments which suggested that AA regulates steroidogenesis at the rate-limiting step of mitochondrial cholesterol transfer (14, 15) .
The manner in which AA regulates StAR protein expression is currently unknown.
The present study demonstrated that this fatty acid regulates StAR gene transcription. As mentioned earlier, after AA is released, it is metabolized mainly through three pathways. Our results suggested that among the three, the lipoxygenase pathway may be involved in steroid production and StAR protein expression. Blocking AA metabolism through this pathway using the inhibitor NDGA greatly decreased dbcAMP-induced StAR protein expression and reduced progesterone production significantly (P < 0.01).
While the specificity of NDGA might be questionable, similar results were also obtained when the more specific 5-lipoxygenase inhibitor, AA861, was used. Moreover, the Although PKA activity remained at a high level, inhibition of AA release reduced the dbcAMP-stimulated StAR promoter activity, StAR mRNA, StAR protein and steroid production ( Fig. 1-4) . On the other hand, inhibition of the PKA activity using H89 also progesterone production in the medium was analyzed by RIA and expressed as a percentage of the highest production among the treatments. ** denotes values which are highly significantly lower than dbcAMP stimulation (P < 0.01);
, denotes values which are highly significantly higher than dbcAMP stimulation (P < 0.01). by guest on September 16, 2017 
